TBK1 and melanoma: Amlexanox significantly reduced the constitutive phosphorylation of p65 and p42/44 in SK-Mel-28 melanoma cells, indicating that these targets are involved in the anticancerogenous effects of IKKε/TBK1 inhibition, while Akt1 and p38 might only play a minor role in this context.